Analysts Cut Homebuilder Targets, Lift Pharma and Insurance

Analyst target price moves on August 1 showed a clear split. Wall Street trimmed housing-related names. It raised pharma and insurance.

BLDR took the sharpest hit. Builders FirstSource saw its average analyst target fall to $80.95 from $87.60. That is a drop of nearly 8%. The $7.1 billion homebuilder carries 6.2% short interest as a percentage of free float. Bears and analysts appear aligned on caution in the housing sector.

AJG moved the other way. Arthur J. Gallagher's average target rose to $286.67 from $281.39. The $65.9 billion insurance broker has just 3.1% short interest. Analysts see upside in specialty insurance names.

ABBV also got a bump. AbbVie's consensus target ticked up to $269.50 from $268.68. The pharma giant is valued at $455 billion. Short sellers are largely absent, with SI at just 1.3% of free float.

AEP saw its target slip slightly to $145.52 from $145.67. The utility's consensus held steady with 13 buy recommendations unchanged. That signals no major conviction shift on utilities.

KKR also received a target lift to $124.78 from $123.48. Analysts remain bullish on alternative asset managers heading into late 2026.